MyFinsight

HomeBlogAbout

MyFinsight

Making company financials insightful for everyone

  • About
  • Blog
  • Privacy Policy
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

Balance Sheets Overview

Current Ratio
830.31%
Quick Ratio
830.31%
Cash Ratio
239.00%
Debt to Asset Ratio
18.81%
Unit: Thousand (K) dollars
Assets Breakdown
    • Marketable securities
    • Cash and cash equivalents
    • Operating lease right-of-use ass...
    • Others
Liabilities Breakdown
    • Additional paid-in capital
    • Accumulated deficit
    • Operating lease liabilities - no...
    • Others
Balance Sheets
2026-06-30
2026-03-31
Cash and cash equivalents
135,359
160,575
Marketable securities
322,056
356,066
Restricted cash and cash equivalents (vie)
0
0
Prepaid expenses and other current assets
12,838
18,749
Total current assets
470,253
535,390
Total property and equipment
82,059
79,367
Less accumulated depreciation
54,754
51,530
Property and equipment, net
27,305
27,837
Operating lease right-of-use assets
55,074
57,765
Other assets
9,058
4,745
Total assets
561,690
625,737
Accounts payable
5,653
7,617
Accrued expenses and other current liabilities
25,196
19,267
Deferred revenue - current
12,168
17,244
Current portion of finance lease liabilities
3,744
3,883
Operating lease liabilities - current
9,875
10,378
Total current liabilities
56,636
58,389
Warrant to purchase convertible preferred stock
0
0
Finance lease liabilities, net of current portion
1,366
2,221
Deferred revenue - non-current
0
1,238
Operating lease liabilities - non-current
47,643
49,088
Other long term liabilities
0
0
Total liabilities
105,645
110,936
Convertible preferred stock
0
0
Non-controlling interest
0
0
Common stock, par value 0.001 500,000,000 and 200,456,735 shares authorized as of june 30, 2026 and december 31, 2025 respectively 128,269,428 and 33,116,957 shares issued and outstanding as of june 30, 2026 and december 31, 2025, respectively
128
128
Additional paid-in capital
1,261,040
1,252,388
Accumulated other comprehensive (loss) income
-129
24
Accumulated deficit
-804,994
-737,739
Total stockholders' equity (deficit)
456,045
514,801
Total liabilities, convertible preferred stock, non-controlling interests and stockholders' equity (deficit)
561,690
625,737
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.

Time Plot

Show the time plot by selecting a row from the table.

Balance Sheets

Marketable securities$322,056K Cash and cashequivalents$135,359K Prepaid expenses andother current assets$12,838K Total property andequipment$82,059K Total current assets$470,253K Operating leaseright-of-use assets$55,074K Property and equipment,net$27,305K Other assets$9,058K Less accumulateddepreciation$54,754K Total assets$561,690K Total liabilities,convertible preferred...$561,690K Total stockholders'equity (deficit)$456,045K Total liabilities$105,645K Accumulated deficit-$804,994K Accumulated othercomprehensive (loss) income-$129K Additional paid-in capital$1,261,040K Total currentliabilities$56,636K Operating leaseliabilities - non-current$47,643K Finance leaseliabilities, net of current...$1,366K Common stock, par value0.001 500,000,000 and...$128K Accrued expenses andother current...$25,196K Deferred revenue -current$12,168K Operating leaseliabilities - current$9,875K Accounts payable$5,653K Current portion offinance lease...$3,744K

Generate Biomedicines, Inc. (GENB)

Generate Biomedicines, Inc. (GENB)